Stocks Comparison
Cencora vs DataMeds AI: revenue, profit, margins and growth compared
Cencora brought in $321.3B of revenue in fiscal 2025, DataMeds AI $23.3M in fiscal 2025. Revenue changed by +9.3% at Cencora and +28.7% at DataMeds AI on the year before, so DataMeds AI grew faster. Cencora kept 0.5% of its revenue as net profit, DataMeds AI -433.9%.
Side by side, latest fiscal year
| COR | MEDS | |
|---|---|---|
| Fiscal year ended | FY2025 (September 30, 2025) | FY2025 (December 31, 2025) |
| Revenue | $321.3B | $23.3M |
| Revenue growth | +9.3% | +28.7% |
| Net income | $1.6B | -$101.3M |
| Net margin | 0.5% | -433.9% |
| Free cash flow | $3.2B | n/a |
| Free cash flow margin | 1.0% | n/a |
| Earnings per share (diluted) | $7.96 | -$1.43 |
| Cash | $4.4B | $42.6K |
| Debt | $7.7B | $23.5M |
| Price to earnings | 38.6 | n/a |
| Market value | $58.6B | $9.1M |
| Dividend yield | 0.72% | n/a |
| Rank by revenue in sector | #3 of 646 · Health care | #426 of 646 · Health care |
Over the years
Questions about Cencora and DataMeds AI
Which is bigger by revenue, Cencora or DataMeds AI?
Cencora is bigger by revenue: $321.3B in fiscal 2025, against $23.3M for DataMeds AI in fiscal 2025.
Which keeps more of its revenue as profit, Cencora or DataMeds AI?
Cencora had a net margin of 0.5% in fiscal 2025; DataMeds AI had -433.9% in fiscal 2025.
Which grew revenue faster, Cencora or DataMeds AI?
In their latest fiscal years revenue changed by +9.3% at Cencora and +28.7% at DataMeds AI.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.